For: | Almhanna K, Strosberg JR. Multimodality approach for locally advanced esophageal cancer. World J Gastroenterol 2012; 18(40): 5679-5687 [PMID: 23155307 DOI: 10.3748/wjg.v18.i40.5679] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v18/i40/5679.htm |
Number | Citing Articles |
1 |
Manavalan Vijayakumar, Rajaram Burrah, Kaushik Hari, K. V. Veerendra, S. Krishnamurthy. Esophagectomy for Cancer of the Esophagus. A Regional Cancer Centre Experience. Indian Journal of Surgical Oncology 2013; 4(4): 332 doi: 10.1007/s13193-013-0260-9
|
2 |
CAROL O’CALLAGHAN, LIAM J. FANNING, AILEEN HOUSTON, ORLA P. BARRY. Loss of p38δ mitogen-activated protein kinase expression promotes oesophageal squamous cell carcinoma proliferation, migration and anchorage-independent growth. International Journal of Oncology 2013; 43(2): 405 doi: 10.3892/ijo.2013.1968
|
3 |
Maurizio Marzaro, Gianantonio Pozzato, Stefano Tedesco, Mattia Algeri, Alessandro Pozzato, Luigi Tomao, Ilaria Montano, Filippo Torroni, Valerio Balassone, Anna Chiara Iolanda Contini, Luciano Guerra, Tommaso D’Angelo, Giovanni Federici di Abriola, Lorenzo Lupoi, Maria Emiliana Caristo, Ivo Boškoski, Guido Costamagna, Paola Francalanci, Giuseppe Astori, Angela Bozza, Andrea Bagno, Martina Todesco, Emanuele Trovalusci, Luigi Dall’ Oglio, Franco Locatelli, Tamara Caldaro. Decellularized esophageal tubular scaffold microperforated by quantum molecular resonance technology and seeded with mesenchymal stromal cells for tissue engineering esophageal regeneration. Frontiers in Bioengineering and Biotechnology 2022; 10 doi: 10.3389/fbioe.2022.912617
|
4 |
Stefan Mönig, Sander van Hootegem, Mickael Chevallay, Bas P.L. Wijnhoven. The role of surgery in advanced disease for esophageal and junctional cancer. Best Practice & Research Clinical Gastroenterology 2018; : 91 doi: 10.1016/j.bpg.2018.11.002
|
5 |
Yoshihiro Tanaka, Takao Takahashi, Kazuya Yamaguchi, Shinji Osada, Toshio Shimokawa, Kazuhiro Yoshida. Elemental diet plus glutamine for the prevention of mucositis in esophageal cancer patients receiving chemotherapy: a feasibility study. Supportive Care in Cancer 2016; 24(2): 933 doi: 10.1007/s00520-015-2864-9
|
6 |
Nelson Adami ANDREOLLO, Valdir TERCIOTI Jr., Luiz Roberto LOPES, João de Souza COELHO-NETO. NEOADJUVANT CHEMORADIOTHERAPY AND SURGERY COMPARED WITH SURGERY ALONE IN SQUAMOUS CELL CARCINOMA OF THE ESOPHAGUS. Arquivos de Gastroenterologia 2013; 50(2): 101 doi: 10.1590/S0004-28032013000200016
|
7 |
Yoshihiro Tanaka, Kazuhiro Yoshida, Atsuko Yamada, Toshiyuki Tanahashi, Naoki Okumura, Nobuhisa Matsuhashi, Kazuya Yamaguchi, Tatsuhiko Miyazaki. Phase II trial of biweekly docetaxel, cisplatin, and 5-fluorouracil chemotherapy for advanced esophageal squamous cell carcinoma. Cancer Chemotherapy and Pharmacology 2016; 77(6): 1143 doi: 10.1007/s00280-016-2985-y
|
8 |
Suresh Raghunath, Richa Tiwari, S. Rashmi, S N Geetha, Raahin Sulthana, Irappa Madabhavi. Impact of radical dose escalation by endoluminal brachytherapy and induction chemotherapy in the definitive treatment of locally advanced esophageal cancer - A retrospective study. Journal of Cancer Research and Therapeutics 2022; 18(Suppl 2): S280 doi: 10.4103/jcrt.jcrt_1783_22
|
9 |
Kewei Ren, Wenzhe Zhang, Gang Wu, Jianzhuang Ren, Huibin Lu, Zongming Li, Xinwei Han. Synergistic anti-cancer effects of galangin and berberine through apoptosis induction and proliferation inhibition in oesophageal carcinoma cells. Biomedicine & Pharmacotherapy 2016; 84: 1748 doi: 10.1016/j.biopha.2016.10.111
|
10 |
Leiguang Ye, Songlei Guan, Cong Zhang, Kuang-Hui Lee, Shilong Sun, Jun Wei, Baogang Liu. Circulating autoantibody to FOXP3 may be a potential biomarker for esophageal squamous cell carcinoma. Tumor Biology 2013; 34(3): 1873 doi: 10.1007/s13277-013-0729-8
|
11 |
|
12 |
Dhirendra Singh, Arpit Saini, Randhir Singh, Rohini Agrawal. Galangin, as a Potential Anticancer Agent. Revista Brasileira de Farmacognosia 2022; 32(3): 331 doi: 10.1007/s43450-022-00238-w
|
13 |
Yinan Liu, Jinfeng Chen, Ningsheng Shao, Yuan Feng, Yuzhao Wang, Lijian Zhang. Clinical value of hematologic test in predicting tumor response to neoadjuvant chemotherapy with esophageal squamous cell carcinoma. World Journal of Surgical Oncology 2014; 12(1) doi: 10.1186/1477-7819-12-43
|
14 |
Biniyam Tefera Deressa, Wondemagegnehu Tigeneh, Netsanet Bogale, Milly Buwenge, Alessio G. Morganti, Eleonora Farina. Short-Course 2-Dimensional Radiation Therapy in the Palliative Treatment of Esophageal Cancer in a Developing Country: A Phase II Study (Sharon Project). International Journal of Radiation Oncology*Biology*Physics 2020; 106(1): 67 doi: 10.1016/j.ijrobp.2019.10.004
|
15 |
|
16 |
Damodara Kumaran, Subhashini John, Rajesh Isiah, Saikat Das. Management of Locally Advanced Carcinoma Oesophagus with Radiation/Chemoradiation: Single Institute Experience. Journal of Gastrointestinal Cancer 2016; 47(3): 313 doi: 10.1007/s12029-016-9825-5
|
17 |
Tiffany M. Rabe, Takeshi Yokoo, Jeffrey Meyer, Kemp H. Kernstine, David Wang, Gaurav Khatri. Radiation-Induced Liver Injury Mimicking Metastatic Disease in a Patient With Esophageal Cancer. Journal of Computer Assisted Tomography 2016; 40(4): 560 doi: 10.1097/RCT.0000000000000406
|
18 |
Yoshihiro Tanaka, Kazuhiro Yoshida, Toshiyuki Tanahashi, Naoki Okumura, Nobuhisa Matsuhashi, Kazuya Yamaguchi. Phase II trial of neoadjuvant chemotherapy with docetaxel, nedaplatin, and S1 for advanced esophageal squamous cell carcinoma. Cancer Science 2016; 107(6): 764 doi: 10.1111/cas.12943
|
19 |
Y. Hu, Z. Li, D.-H. Mi, N. Cao, S.-W. Zu, Z.-Z. Wen, X.-L. Yu, Y. Qu. Chemoradiation combined with regional hyperthermia for advanced oesophageal cancer: a systematic review and meta-analysis. Journal of Clinical Pharmacy and Therapeutics 2017; 42(2): 155 doi: 10.1111/jcpt.12498
|